Haemonetics (HAE) EBITDA Margin (2009 - 2026)
Haemonetics (HAE) posted quarterly EBITDA Margin of 6.65% for Q1 2026, down 2823.0% year-over-year from 0.24% in Q1 2025, and down 133.44% quarter-over-quarter from 19.88% in Q4 2025.
Haemonetics (HAE) EBITDA Margin (2009 - 2026) Analysis & Trends
Haemonetics' EBITDA Margin history runs 18 years deep, the most recent figure standing at 6.65% for Q1 2026.
- In Q1 2026, EBITDA Margin fell 2823.0% year-over-year to 6.65%; the TTM figure through Mar 2026 stood at 11.75% (down 455.0% YoY), while the FY2026 annual figure was 11.75%, down 455.0% from the prior year.
- EBITDA Margin for Q1 2026 stood at 6.65%, down from 19.88% in the prior quarter.
- The five-year high for EBITDA Margin was 21.58% in Q1 2025, with the low at 6.65% in Q1 2026.
- The 5-year median for EBITDA Margin is 13.95% (2022), against an average of 13.23%.
- The sharpest annual moves came in 2022 and 2026: EBITDA Margin soared 1665 bps in 2022, then plunged 2823 bps in 2026.
- Haemonetics' EBITDA Margin stood at 14.18% in 2022, then retreated by 4 bps to 13.67% in 2023, then rose by 24 bps to 16.94% in 2024, then climbed by 17 bps to 19.88% in 2025, then sank by 133 bps to 6.65% in 2026.
- Business Quant data shows HAE's EBITDA Margin at 6.65% in Q1 2026, 19.88% in Q4 2025, and 17.87% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.90 Bn | 194.30 Bn | 7.27 Bn | 13.44% |
| 2 | Stryker | 130.01 Bn | 126.54 Bn | 4.50 Bn | 25.18% |
| 3 | Medtronic | 120.53 Bn | 111.31 Bn | 6.41 Bn | 19.10% |
| 4 | Boston Scientific | 74.77 Bn | 74.24 Bn | 3.85 Bn | 21.65% |
| 5 | Edwards Lifesciences | 52.74 Bn | 48.49 Bn | 1.35 Bn | 29.48% |
| 6 | Dexcom | 34.74 Bn | 32.79 Bn | 830.00 Mn | 24.33% |
| 7 | GE HealthCare Technologies | 33.78 Bn | 31.67 Bn | 2.18 Bn | 13.96% |
| 8 | Koninklijke Philips | 26.43 Bn | 23.11 Bn | 4.55 Bn | 10.30% |
| 9 | Steris | 23.15 Bn | 22.67 Bn | 684.20 Mn | 19.15% |
| 10 | Haemonetics | 4.91 Bn | 4.69 Bn | 202.80 Mn | 16.93% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | 16.93% |
| Mar 28, 2026 | -6.65% |
| Dec 27, 2025 | 19.88% |
| Sep 27, 2025 | 17.87% |
| Jun 28, 2025 | 16.76% |
| Mar 29, 2025 | 21.58% |
| Dec 28, 2024 | 16.94% |
| Sep 28, 2024 | 14.96% |
| Jun 29, 2024 | 11.83% |
| Mar 30, 2024 | 8.72% |
| Dec 30, 2023 | 13.67% |
| Sep 30, 2023 | 11.10% |
| Jul 1, 2023 | 17.24% |
| Apr 1, 2023 | 11.58% |
| Dec 31, 2022 | 14.18% |
| Oct 1, 2022 | 15.71% |
| Jul 2, 2022 | 11.77% |
| Apr 2, 2022 | 7.24% |
| Jan 1, 2022 | 13.72% |
| Oct 2, 2021 | 10.22% |